NUTM2D
NUT family member 2D
Also known as: FAM22D, NTM2D_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5VT03
- Gene
- NUTM2D
- Ensembl
- ENSG00000214562
- Chromosome
- 10
- Canonical length
- 806 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins
- Subcellular location
- Nuclear bodies
OverviewNCBI Gene
No narrative summary is available for NUTM2D in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
806 residues, UniProt reviewed canonical sequence.
>Q5VT03|NUTM2D
1 MFQEPVYFQI FLFQLDSGAS GEPGHSLGLT LGFSHCGNCQ TAVVSAQPEG MASNGAYPAL
61 GPGVTANPGT SLSVFTALPF TTPAPGPAHG PLLVTAGAPP GGPLVLSNFP STPLVTEQDG
121 CGPSGAGASN VFVQMRTEVG PVKAAQAQTL VLTQTPLVWQ APGALCGGVV CPPPLLLAAA
181 PVVPVMAAQV VGGTQACEGG WSQGLPLPPP PPPAAQLPPI VSQGNAGPWP QGAHGEGSLA
241 SSQAKAPPDD SCNPRSVYEN FRLWQHYKPL ARRHLPQSPD TEALSCFLIP VLRSLARRKP
301 TMTLEEGLWR AMREWQHTSN FDRMIFYEMA EKFLEFEAEE EMQIQKSQWM KGPQCLPPPA
361 TPRLEPRGPP APEVVKQPVY LPSKAGPKAP TACLPPPRPQ RPVTKARRPP PRPHRRAETK
421 ARLPPPRPQR PAETKVPEEI PPEVVQEYVD IMEELLGPSL GATGEPEKQR EEGEVKQPQE
481 EDWTPPDPGL LSYTDKLCSQ KDFVTKVEAV IHPQFLEELL SPDPQMDFLA LSQELEQEEG
541 LTLAQLVEKR LLPLKEKQHA RAAPSRGTAR LDSSSSKFAA GQGAERDVPD PQQGVGMETC
601 PPQTTARDSQ GRGRAHTGMA RSKDSVVLLG CQDSPGLRAA RPTSPPQDHR PTCPGVGTKD
661 ALDLPGGSPV RESHGLAQGS SEEEELPSLA FLLGSQHKLL PWWLPQSPVP ASGLLSPEKW
721 GPQGTHQSPS AERRGLNLAP SPANKAKKRP LFGSLSPAEK TPHPGPGLRV SGEQSLTWGL
781 GGPSQSQKRK GDPLVSRKEK KQRCSQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NUTM2D can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.63
- Highest tissue expression
- 6.8 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 6.8 nTPM
- hippocampal formation: 6 nTPM
- midbrain: 5.6 nTPM
- heart muscle: 5.5 nTPM
- amygdala: 5.4 nTPM
- kidney: 5.1 nTPM
Single-cell type
- epicardial cells: 9.1 nCPM
- cardiomyocytes: 4.5 nCPM
- retinal ganglion cells: 3.9 nCPM
- adipocytes: 1.1 nCPM
- endometrial secretory cells: 1 nCPM
- vascular smooth muscle cells: 0.9 nCPM
Immune cell
- eosinophil: 0.1 nTPM
- naive B-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- white matter: 33 nTPM
- cerebral cortex: 32 nTPM
- medulla oblongata: 29 nTPM
- basal ganglia: 27 nTPM
- thalamus: 27 nTPM
- pons: 27 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.99
- gnomAD pLI
- 0.37
- gnomAD missense Z
- 0.1
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NUTM2D as an antibody target. Whether an autoantibody or antibody against NUTM2D could matter depends on whether native NUTM2D is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NUTM2D is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NUTM2D as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...